I spent the next two hours writing an opinion piece for the Chronicle titled "On Pharmaceutical Wealth and Media Responsibility: A Personal Perspective." The article acknowledged my family's billions while discussing the ethics of using wealth to control information, the difference between editorial independence and coordinated harassment, and why students had the right to defend themselves against smear campaigns.
It was honest, thoughtful, and strategically positioned to counter Harrison's narrative about wealthy students silencing legitimate criticism.
"This is good," Nick said after reading my draft. "It addresses the ownership concerns while reframing the acquisition as protection rather than censorship."
"It also makes me a target for anyone who thinks pharmaceutical heiresses sho
